ICR142 Benchmarker: evaluating, optimising and benchmarking variant calling performance using the ICR142 NGS validation series

Evaluating, optimising and benchmarking of next generation sequencing (NGS) variant calling performance are essential requirements for clinical, commercial and academic NGS pipelines. Such assessments should be performed in a consistent, transparent and reproducible fashion, using independently, orthogonally generated data. Here we present ICR142 Benchmarker, a tool to generate outputs for assessing germline base substitution and indel calling performance using the ICR142 NGS validation series, a dataset of Illumina platform-based exome sequence data from 142 samples together with Sanger sequence data at 704 sites. ICR142 Benchmarker provides summary and detailed information on the sensitivity, specificity and false detection rates of variant callers. ICR142 Benchmarker also automatically generates a single page report highlighting key performance metrics and how performance compares to widely-used open-source tools. We used ICR142 Benchmarker with VCF files outputted by GATK, OpEx and DeepVariant to create a benchmark for variant calling performance. This evaluation revealed pipeline-specific differences and shared challenges in variant calling, for example in detecting indels in short repeating sequence motifs. We next used ICR142 Benchmarker to perform regression testing with DeepVariant versions 0.5.2 and 0.6.1. This showed that v0.6.1 improves variant calling performance, but there was evidence of minor changes in indel calling behaviour that may benefit from attention. The data also allowed us to evaluate filters to optimise DeepVariant calling, and we recommend using 30 as the QUAL threshold for base substitution calls when using DeepVariant v0.6.1. Finally, we used ICR142 Benchmarker with VCF files from two commercial variant calling providers to facilitate optimisation of their in-house pipelines and to provide transparent benchmarking of their performance. ICR142 Benchmarker consistently and transparently analyses variant calling performance based on the ICR142 NGS validation series, using the standard VCF input and outputting informative metrics to enable user understanding of pipeline performance. ICR142 Benchmarker is freely available at https://github.com/RahmanTeamDevelopment/ICR142_Benchmarker/releases.

[1]  Donghe Li,et al.  Comparison of INDEL Calling Tools with Simulation Data and Real Short-Read Data , 2019, IEEE/ACM Transactions on Computational Biology and Bioinformatics.

[2]  S. Ellard,et al.  Diagnosis of lethal or prenatal‐onset autosomal recessive disorders by parental exome sequencing , 2017, Prenatal diagnosis.

[3]  Sarah Sandmann,et al.  Evaluating Variant Calling Tools for Non-Matched Next-Generation Sequencing Data , 2017, Scientific Reports.

[4]  Cory Y. McLean,et al.  Creating a universal SNP and small indel variant caller with deep neural networks , 2016, bioRxiv.

[5]  Nazneen Rahman,et al.  OpEx - a validated, automated pipeline optimised for clinical exome sequence analysis , 2016, Scientific Reports.

[6]  S. Seal,et al.  The ICR142 NGS validation series: a resource for orthogonal assessment of NGS analysis , 2016, F1000Research.

[7]  Ewa A. Bergmann,et al.  Indel variant analysis of short-read sequencing data with Scalpel , 2015, Nature Protocols.

[8]  Nazneen Rahman,et al.  CSN and CAVA: variant annotation tools for rapid, robust next-generation sequencing analysis in the clinical setting , 2015, Genome Medicine.

[9]  G. McVean,et al.  Integrating mapping-, assembly- and haplotype-based approaches for calling variants in clinical sequencing applications , 2014, Nature Genetics.

[10]  Heng Li,et al.  Toward better understanding of artifacts in variant calling from high-coverage samples , 2014, Bioinform..

[11]  Christopher A. Miller,et al.  VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. , 2012, Genome research.

[12]  M. DePristo,et al.  A framework for variation discovery and genotyping using next-generation DNA sequencing data , 2011, Nature Genetics.

[13]  Alexis B. Carter,et al.  Standards and Guidelines for Validating Next-Generation Sequencing Bioinformatics Pipelines: A Joint Recommendation of the Association for Molecular Pathology and the College of American Pathologists. , 2018, The Journal of molecular diagnostics : JMD.

[14]  Sequence analysis Advance Access publication June 7, 2011 The variant call format and VCFtools , 2010 .